Neurological disorder is associated with dysfunction in any part of
the brain or nervous system, resulting in physical and/or
psychological symptoms. Various neurological disorders are
congenital, which emerge during the early years of embryo
developmental and may be diagnosed at birth. Whereas, acquired
neurological disorders develop after the birth due to traumatic brain
injuries, immune disorders, postnatal injections, spinal cord
injuries, neoplasm, and exposure to environmental chemicals or
toxins, among others.
Many bacterial (Mycobacterial tuberculosis, Neisseria meningitides),
viral (Human Immunodeficiency Virus (HIV), Enteroviruses, West Nile
Virus, Zika), fungal (Cryptococcus, Aspergillus), and parasitic
(malaria, Chagas) infections can also affect the nervous system,
resulting in neurological disorders.
Ask
For In-Depth Sample Copy of Research @
https://www.coherentmarketinsights.com/insight/request-sample/2363
Neurological Disorder Drugs Market: Drivers
Rising awareness associated with early disease diagnosis through
awareness campaigns by government regulatory bodies and private
organizations, and market entry of efficient drugs in the near
future, owing to the presence of strong drug pipeline is expected to
drive growth of the neurological disorder drugs market.
For instance, according to a report published by the Pharmaceutical
Research and Manufacturers of America (PhRMA) in April 2018, there
are currently 537 medicines in development by biopharmaceutical
companies in the U.S for various neurological disorders. This mainly
includes 95 medicines for brain tumors, 46 for chronic pain, and 92
for Alzheimer’s disease. The other 30 are being developed for a
range of conditions including multiple sclerosis, migraines,
amyotrophic lateral sclerosis, and Parkinson’s disease.
Neurological Disorder Drugs Market: Regional Analysis
North America is expected to hold a dominant position in the global
neurological disorder drugs market and account for the largest market
share over the forecast period, owing to high presence of key players
in the region and approval and launch of novel products by them in
the region.
For instance, in May 2018, Amgen received the U.S. FDA approval for
Aimovig (erenumab-aooe), for the preventive treatment of migraine in
adults. Aimovig is a novel therapeutic approach and the only
FDA-approved treatment specifically developed to prevent migraine by
blocking the calcitonin gene-related peptide receptor (CGRP-R), which
plays a critical role in migraine.
Neurological Disorder Drugs Market: Key Players
Key players operating in the global neurological disorder drugs
market include Amgen Inc., UCB S.A., Neurocrine Biosciences, Inc.,
Pfizer Inc., Biogen Inc., Teva Pharmaceutical Industries Ltd., AcelRx
Pharmaceuticals, Inc., Eli Lilly and Company, Ionis Pharmaceuticals,
Inc., Adamas Pharmaceuticals, Inc., BioMarin Pharmaceutical Inc.,
Otsuka America Pharmaceutical, Inc., AstraZeneca plc, and Novartis
International AG.
Neurological Disorder Drugs Market: Taxonomy
The global neurological disorder drugs market is segmented on the
basis of drug type, disease type, distribution channel, and region.
By Drug Type:
-
Antipsychotic
-
Antiepileptic
-
Anticholinergic
-
Analgesics
-
Hypnotic & Sedative
-
Anticoagulants
-
Antihypertensive
By Disease Type:
-
Epilepsy
-
Parkinson’s disease
-
Alzheimer’s disease
-
Cerebrovascular disease
-
Multiple Sclerosis
-
Others
By Distribution Channel:
-
Hospitals Pharmacies
-
Retail Pharmacies
-
Online pharmacies
By Region:
-
North America
-
Latin America
-
Europe
-
Asia Pacific
-
Middle East
-
Africa
For
More Information, Browse Full Report Here:
https://www.coherentmarketinsights.com/ongoing-insight/neurological-disorder-drugs-market-2363
Also,
Coherent Market Insights has a proprietary database of pipeline
biologics and biosimilars, called PHASE-XS. This database provides
analytical data in addition to the clinical information of ongoing
trials for biologics and biosimilars. An amalgamation of more than 30
parameters, PHASE-XS helps biotechnology and pharmaceutical companies
to analyze the market trend, competition, and market potential. For
more information or to access this database, kindly click on the
below link or contact at sales@coherentmarketinsights.com
About Coherent Market Insights:
Coherent Market Insights is a prominent market research and
consulting firm offering action-ready syndicated research reports,
custom market analysis, consulting services, and competitive analysis
through various recommendations related to emerging market trends,
technologies, and potential absolute dollar opportunity.
Contact Us:
Mr. Shah
Coherent Market Insights
1001 4th Ave,
#3200
Seattle, WA 98154
Tel: +1-206-701-6702
No comments:
Post a Comment